<DOC>
	<DOCNO>NCT02127775</DOCNO>
	<brief_summary>This study assess bioequivalence lesinurad tablet manufacture two different site .</brief_summary>
	<brief_title>Lesinurad Tablet Bioequivalence</brief_title>
	<detailed_description>This study intend evaluate clinical comparability lesinurad tablet manufacture 2 different site assess relevant clinical Pharmacokinetics ( PK ) parameter .</detailed_description>
	<mesh_term>Lesinurad</mesh_term>
	<criteria>Subject body weight ≥ 50 kg ( 110 lb . ) body mass index ≥ 18 ≤ 40 kg/m2 . Subject Screening serum urate level ≤ 7 mg/dL . ˗ Subject free clinically significant disease medical condition , per Investigator 's judgment . Subject gastrointestinal disorder affect motility and/or absorption . Subject history suspicion kidney stone . Subject undergone major surgery within 3 month prior Screening . Subject donate blood experienced significant blood loss ( &gt; 450 mL ) within 12 week prior Day 1 give plasma donation within 4 week prior Screening visit . Subject inadequate venous access unsuitable vein repeat venipuncture .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>